Phase II Study of Docetaxel and S-1 (DS) as Neoadjuvant Chemotherapy for Clinical Stage III Resectable Gastric Cancer

Title
Phase II Study of Docetaxel and S-1 (DS) as Neoadjuvant Chemotherapy for Clinical Stage III Resectable Gastric Cancer
Authors
Keywords
Gastric Cancer, Overall Survival, Docetaxel, Advanced Gastric Cancer, Pathological Response
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 21, Issue 7, Pages 2340-2346
Publisher
Springer Nature
Online
2014-03-07
DOI
10.1245/s10434-014-3594-9

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now